Immunological mechanisms and antibody-drug conjugates targeting B7-H3 and B7-H4 in ovarian cancer
Ovarian cancer remains the most lethal gynecologic malignancy, with immune evasion a major driver of therapeutic resistance and disease progression. Among novel targets, the immune checkpoint molecules B7-H3 and B7-H4 have been recognized for their pot…